Ibogaine Administration Modifies GDNF and BDNF Expression in Brain Regions Involved in Mesocorticolimbic and Nigral Dopaminergic Circuits. Read More > March 5, 2019
5-methoxy-N,N-dimethyltryptamine (5-MeO-DMT) used in a naturalistic group setting is associated with unintended improvements in depression and anxiety Read More > March 1, 2019
Recreational use of psychedelics is associated with elevated personality trait openness: Exploration of associations with brain serotonin markers Read More > February 28, 2019
Sub-Acute Effects of Psilocybin on Empathy, Creative Thinking, and Subjective Well-Being Read More > February 28, 2019
Investigation of medical effect of multiple ketamine infusions on patients with major depressive disorder Read More > February 21, 2019
Effective connectivity changes in LSD-induced altered states of consciousness in humans Read More > February 12, 2019
Psychedelic medicine: The biology underlying the persisting psychedelic effects. Read More > February 11, 2019
Psychedelic effects of psilocybin correlate with serotonin 2A receptor occupancy and plasma psilocin levels. Read More > January 26, 2019
Effects of acute and repeated treatment with serotonin 5-HT2A receptor agonist hallucinogens on intracranial self-stimulation in rats Read More > January 10, 2019
